A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Clinical trial NCT02614716 · COMPLETED
Trial details
- NCT number
- NCT02614716
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-10
- Primary completion
- 2018-09-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.